LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 213 filers reported holding LOXO ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,434,000 | -23.2% | 67,353 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $12,283,000 | -23.8% | 71,903 | -22.6% | 0.00% | 0.0% |
| Q2 2018 | $16,126,000 | +413.2% | 92,956 | +241.4% | 0.00% | – |
| Q1 2018 | $3,142,000 | +188.5% | 27,227 | +110.3% | 0.00% | – |
| Q4 2017 | $1,089,000 | -14.2% | 12,944 | -6.0% | 0.00% | – |
| Q3 2017 | $1,269,000 | +231.3% | 13,769 | +187.5% | 0.00% | – |
| Q2 2017 | $383,000 | +11.3% | 4,789 | -41.4% | 0.00% | – |
| Q1 2017 | $344,000 | +244.0% | 8,176 | +162.6% | 0.00% | – |
| Q4 2016 | $100,000 | +35.1% | 3,113 | +9.5% | 0.00% | – |
| Q3 2016 | $74,000 | +17.5% | 2,842 | +4.1% | 0.00% | – |
| Q2 2016 | $63,000 | +14.5% | 2,729 | +35.5% | 0.00% | – |
| Q1 2016 | $55,000 | +3.8% | 2,014 | +6.9% | 0.00% | – |
| Q4 2015 | $53,000 | +51.4% | 1,884 | -5.9% | 0.00% | – |
| Q3 2015 | $35,000 | -7.9% | 2,003 | -4.0% | 0.00% | – |
| Q2 2015 | $38,000 | -44.1% | 2,087 | -61.8% | 0.00% | – |
| Q1 2015 | $68,000 | – | 5,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |